Treatment of Hypertension in Chronic Kidney Disease

Rigas G Kalaitzidis1, Moses S Elisaf2

  • 1Department of Nephrology, University Hospital of Ioannina, 455 00, Ioannina, Greece. rigaska@gmail.com.

Insights

Managing hypertension in chronic kidney disease (CKD) involves a blood pressure goal below 130/80 mmHg. Key treatments include ACE inhibitors, ARBs, and diuretics, with CCBs used cautiously.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) is a global health issue.
  • Hypertension is a common comorbidity that worsens with declining kidney function.

Purpose of the Study:

  • To review current treatment options for hypertension in CKD patients.
  • To highlight updated hypertension guidelines for CKD management.

Main Methods:

  • Review of current hypertension guidelines.
  • Analysis of antihypertensive medication classes for CKD patients.

Main Results:

  • Updated guidelines recommend a blood pressure goal < 130/80 mmHg for CKD patients.
  • Angiotensin-converting enzyme (ACE) inhibitors are first-line agents, with Angiotensin II receptor blockers (ARBs) as alternatives.
  • Non-dihydropyridine calcium channel blockers (CCBs) reduce albuminuria; dihydropyridine CCBs require combination therapy with RAAS blockers.

Conclusions:

  • Intensive blood pressure control is crucial for CKD patients.
  • A stepwise approach using ACE inhibitors/ARBs, diuretics, and CCBs is recommended.
  • Lifestyle modifications and pharmacotherapy are essential for managing hypertension in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
742
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
674
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
482
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
404
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968